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ABSTRACT 
 Chemical exchange saturation transfer (CEST) and magnetization transfer (MT) are types 
of magnetic resonance imaging (MRI) experiments in which contrast is based on the transfer of 
magnetization from selectively saturated solute or macromolecular protons to bulk water protons. 
These processes offer insight into the chemical composition of tissue and are quantified by the 
asymmetry of the magnetization transfer ratio (MTRasym). This study was to develop a Z-spectral 
curve fitting procedure based on the underlying physics of CEST-MRI from which MTRasym 
values can be calculated and applied to distinguish healthy tissue from cancer. 
 Z-spectra were collected from CEST-MR images of a phantom. The data were fit to both 
the proposed model which separately fits the upfield and downfield regions of the Z-spectra, and 
two polynomial models from literature. A preferred model was identified using the small sample 
bias-corrected Akaike’s Information Criterion (AICc). Z-spectra were collected from CEST-MR 
images of prostate cancer patients and fit with the same models; the preferred model was 
selected using the AICc. CEST-MR images of bladder cancer patients were acquired and the Z-
spectra were fit with the preferred model identified from the phantom images. MTRasym was 
calculated at frequency offsets of 3.5 ppm and 2.0 ppm to determine if these quantities were 
capable of distinguishing normal bladder wall (NBW) from bladder cancer. 
  The proposed fitting model with a 5
th
 order polynomial for the downfield region was the 
preferred curve fitting model by the AICc model selection procedure for the phantom while a 6
th
 
order polynomial was preferred for the prostate cancer Z-spectra. MTRasym(2.0 ppm) values 
calculated from the bladder cancer Z-spectra did not differ significantly between the NBW and 
tumor regions. A statistically significant difference existed between the NBW and tumor regions 
for the MTRasym(3.5 ppm) values (p < 0.001). 
xii 
 
 The proposed model was preferred to the polynomial models from literature based on the 
AICc metric. Application of the technique to patient images showed the potential to distinguish 
NBW from bladder cancer based on the statistically significant MTRasym(3.5 ppm) values in 
these regions. 
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CHAPTER 1: INTRODUCTION 
1.1 MRI PHYSICS REVIEW 
1.1.1 NUCLEAR MAGNETIC RESONANCE 
Some species of nuclei have an intrinsic magnetic moment, which will be oriented 
isotropically in a material under normal conditions. In the presence of a strong external magnetic 
field, these magnetic moments will align to either parallel (low energy) or antiparallel (high 
energy) states to create a net magnetic moment oriented in the direction of the external magnetic 
field (Figure 1.1). The ratio of the number of protons in the low energy state to the number of 
protons in the high energy state is determined by 
 
𝑛𝑠𝑝𝑖𝑛 𝑢𝑝
𝑛𝑠𝑝𝑖𝑛 𝑑𝑜𝑤𝑛
= 𝑒−
ℏ𝛾𝐵0
𝑘𝑇    (1.1) 
where γ represents the gyromagnetic ratio (42.58 MHz/T for hydrogen nuclei), ħ is the 
Dirac constant (1.05 × 10
-34
 Js), k is the Boltzmann constant (1.38 × 10
-23
 m
2
kgs
-2
K
-1
), T is the 
temperature (37˚C for the human body), and B0 is the strength of the external magnetic field 
(Haacke, Brown et al. 1999). The gyromagnetic ratio, γ, is a property of the nucleus. For MR 
imaging of the human body, the hydrogen nucleus due to the large abundance of both water and 
fat in the human body (Westbrook, Roth et al. 2011).  
 
Figure 1.1: (a) Alignment of proton magnetic moments in the absence of a magnetic field, and 
(b) in the presence of a strong external magnetic field. Adapted from Westbrook 2011. 
a) b) 
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 Although the net magnetic moment aligns with the external magnetic field, the magnetic 
moments of the individual hydrogen nuclei maintain an angle of 54.73˚ from the direction of the 
external magnetic field and precess about this field at the resonance or Larmor frequency, ω0, 
given by 
 𝜔0 = 𝛾𝐵0  (1.2) 
where γ is the gyromagnetic ratio and B0 is the strength of the external magnetic field (Figure 
1.2). For hydrogen nuclei in a 3 T external magnetic field, the Larmor frequency is 127.7 MHz.  
 
Figure 1.2: The precession of an individual magnetic moment about the direction of the external 
magnetic field. Adapted from Westbrook 2011. 
 
1.1.2 CHEMICAL SHIFT 
Though all nuclei of a single species have a constant gyromagnetic ratio, the resonance 
frequency of these nuclei can change based on the electronic environment. Changes in geometry 
B0 
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including bond length and bond angle, as well as the electronegativity of elements participating 
in a bond, affect the net magnetic field experienced by an individual nucleus. From Equation 1.2, 
a change in magnetic field strength changes the resonance frequency of the nucleus. This shift is 
often expressed in units of parts per million (ppm or Hz/MHz), calculated as 
 Δ𝜔 =
𝜔−𝜔𝑟𝑒𝑓
𝜔𝑟𝑒𝑓
  (1.3) 
where ω is the resonance frequency of the shifted nucleus and ωref is the resonance frequency of 
a reference material. Tetramethylsilane (TMS) is commonly chosen as a reference material.  
Due to the effect of chemical structure on the resonance frequency of nuclei, NMR 
spectroscopy is able to identify the types of bonds in a sample (Figure 1.3). 
 
Figure 1.3: The amount of chemical shift varies depending on molecular structure and the 
electronegativity of participating atoms. Figure adapted from the University of Colorado's 
organic chemistry NMR theory tutorial (orgchem.colorado.edu). 
 
1.1.3 MAGNETIC SUSCEPTIBILITY 
Magnetic susceptibility is a property of a material that describes the relationship between 
the magnetization of the material and the strength of an applied external magnetic field, which 
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causes differences in the Larmor frequency of protons in the context of MRI. This change in 
Larmor frequency causes signal loss at the interface between materials with different magnetic 
susceptibilities, and the magnitude of the resulting artifact (Figure 1.4) can range from 
insignificant to severe; the presence of ferromagnetic materials especially causes B0 field 
inhomogeneity in surrounding tissues. 
 
Figure 1.4: Magnetic susceptibility artifact due to a metallic substance located on the surface of 
the patient's skin. This case is courtesy of Dr. Ayush Goel of Radiopaedia.org. 
 
The B0 field inhomogeneities caused by differences in magnetic susceptibility between 
tissues and even in regions within a tissue also have an effect on chemical shift and MR 
spectroscopy. The resonance frequency of protons is shifted an amount based on the magnitude 
of the B0 field inhomogeneity as described by the Larmor equation (Equation 1.2). The entire 
MR spectrum becomes shifted laterally along the frequency axis. 
1.2 MAGNETIZATION TRANSFER 
 The T2 relaxation time of protons associated with immobile macromolecules is too short 
for direct imaging with standard 
1
H MRI (Henkelman, Stanisz et al. 2001). However, these 
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macromolecular protons can be detected indirectly based on the interactions with water protons. 
An off-resonance radiofrequency saturation pulse can selectively excite the macromolecular 
spins; the magnetization will subsequently be transferred to water protons (Figure 1.5) through a 
combination of spin-spin interactions and direct chemical exchange of protons. This 
magnetization transfer (MT) process is described using a two pool model, with one pool 
representing the water protons (bulk water pool or free pool) and the other representing the 
macromolecular protons (bound pool), each with their own relaxation rates and an exchange rate 
between the two pools (Figure 1.6). Though the goal of magnetization transfer MRI (MT-MRI) 
is to detect changes in the bulk water pool due to MT from the bound pool, some direct 
saturation of the water pool (direct water saturation, DWS) always occurs when the saturation 
pre-pulse is applied. 
 
Figure 1.5: An off-resonance RF saturation pulse applied to the bound pool reduces the signal 
detected from the water pool following magnetization transfer. Adapted from Henkelman 2001. 
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Figure 1.6: The larger pool (A) representing the water pool, and a smaller macromolecular pool 
(B). The exchange rate R describes the transfer of magnetization between the two pools. Adapted 
from Henkelman 2001. 
 
 The magnetizations of the two pools in this model are described by the Bloch equations, 
modified to include exchange terms: 
 
𝑑𝑀𝑧
𝑎
𝑑𝑡
= 𝑅𝑎(𝑀0
𝑎 − 𝑀𝑧
𝑎) − 𝑅𝑀0
𝑏𝑀𝑧
𝑎 + 𝑅𝑀0
𝑎𝑀𝑧
𝑏 + 𝜔1𝑀𝑦
𝑎  (1.4) 
 
𝑑𝑀𝑧
𝑏
𝑑𝑡
= 𝑅𝑏(𝑀0
𝑏 − 𝑀𝑧
𝑏) − 𝑅𝑀0
𝑎𝑀𝑧
𝑏 + 𝑅𝑀0
𝑏𝑀𝑧
𝑎 + 𝜔1𝑀𝑦
𝑏  (1.5) 
 
𝑑𝑀𝑥
𝑎
𝑑𝑡
= −
𝑀𝑥
𝑎
𝑇2𝑎
− 2𝜋Δ𝑀𝑦
𝑎  (1.6) 
 
𝑑𝑀𝑥
𝑏
𝑑𝑡
= −
𝑀𝑥
𝑏
𝑇2𝑏
− 2𝜋Δ𝑀𝑦
𝑏  (1.7) 
 
𝑑𝑀𝑦
𝑎
𝑑𝑡
= −
𝑀𝑦
𝑎
𝑇2𝑎
+ 2𝜋Δ𝑀𝑥
𝑎 − 𝜔1𝑀𝑧
𝑎  (1.8) 
 
𝑑𝑀𝑦
𝑏
𝑑𝑡
= −
𝑀𝑦
𝑏
𝑇2𝑏
+ 2𝜋Δ𝑀𝑥
𝑏 − 𝜔1𝑀𝑧
𝑏  (1.9) 
where Mi
j
 represents the i
th
 component (x, y, or z) of the magnetization of the j
th
 pool (a = water 
and b = bound), R is the exchange rate, Ra,b is the longitudinal relaxation rates of the water and 
bound pools (A and B), M0
a,b
 is the magnetization in the absence of saturation, Δ is the frequency 
offset of the RF saturation pulse (in Hz), T2a,b is the transverse relaxation times for the water (a) 
and bound (b) pools, and ω1 is the angular frequency of precession caused by the RF saturation 
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pulse (Henkelman, Huang et al. 1993). Assuming steady state, these equations may be solved to 
provide a description of the magnetization of the water pool 
 𝑀𝑧
𝑎 =
𝑅𝑏(
𝑅𝑀0
𝑏
𝑅𝑎
)+𝑅𝑟𝑓𝑏+𝑅𝑏+𝑅
(
𝑅𝑀0
𝑏
𝑅𝑎
)(𝑅𝑏+𝑅𝑟𝑓𝑏)+(1+(
𝜔1
2𝜋Δ
)
2
(
1
𝑅𝑎𝑇2𝑎
)(𝑅𝑏+𝑅𝑟𝑓𝑏+𝑅)
  (1.10) 
where Rrfb is a function describing the RF absorption rate of the bound pool. While the solution 
of Equations 1.4-1.9 suggests a Lorentzian line shape for both the water and bound pools, 
experiments have shown a Gaussian function better fits the bound pool in agar, and a super-
Lorentzian better fits the bound pool in tissue (Morrison and Henkelman 1995). 
 The imaging procedure for MT-MRI consists of a narrow-band RF saturation pre-pulse 
applied immediately prior to the image acquisition sequence (Figure 1.7). Common pulse 
sequences used to acquire these images include 2D single-slice fast spin echo or fast gradient 
echo techniques and 3D echo planar imaging techniques. In principle, the saturation pre-pulse 
can be applied prior to any image acquisition sequence, but in practice, fast imaging techniques 
are preferred to minimize the decay of the MT effect (Zaiss and Bachert 2013). 
 
Figure 1.7: MT-MRI is performed by applying a RF saturation pre-pulse (red, left) prior to a 
standard imaging pulse sequence (right). Adapted from Zaiss 2013. 
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 The effect of MT has been traditionally quantified by the magnetization transfer ratio, or 
MTR, which is calculated as: 
 𝑀𝑇𝑅 = 1 −
𝑆𝑠𝑎𝑡
𝑆0
  (1.11) 
where Ssat is the signal intensity with the saturation pre-pulse and S0 is the signal intensity in the 
absence of saturation.  
 Graphically, the effect of MT may be depicted by plotting signal intensity as a function of 
the frequency offset of the applied saturation pre-pulse (Figure 1.8). This often is called the Z-
spectrum, or MT-spectrum (Bryant 1996). The plotted signal intensity is often normalized by the 
signal intensity in the absence of saturation, so the Z-spectrum may alternatively be thought of as 
the plot of 1-MTR versus the frequency offset of the applied saturation pre-pulse. However, for 
many MT-MRI experiments, the entire Z-spectrum need not be collected; a single image with the 
saturation pre-pulse applied at a sufficiently large frequency offset is often adequate for the 
purpose of MTR calculations (Kumar, Jagannathan et al. 2008). 
 
Figure 1.8: A hypothetical Z-spectrum for conventional MT from immobile macromolecules has 
a large width, with noticeable MT effects at saturation frequency offsets of 100 kHz. Adapted 
from Zhou 2006. 
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1.3 APPLICATIONS OF MAGNETIZATION TRANSFER MRI 
MT-MRI has previously been applied to enhance contrast in MR angiography (Parker, 
Buswell et al. 1995) and brain imaging for multiple sclerosis (Mehta, Pike et al. 1995, Tozer, 
Ramani et al. 2003). Recently, quantitative MT-MRI has been utilized to detect the 
macromolecular protons in the prostate to distinguish cancer from healthy tissue (Arima, 
Hayashi et al. 1999, Kumar, Jagannathan et al. 2008, Kumar, Jagannathan et al. 2012), as 
prostate cancer tissues exhibit greater MT effects than healthy peripheral zone tissues based on 
the greater amount of relatively stationary structural tissue proteins and lipids (Riches 2009). 
MTR has recently been studied as a potential biomarker for bowel fibrosis (Pazahr, Blume et al. 
2013, Martens, Lambregts et al. 2014). As of May 2015, there have been over 1700 publications 
on MT-MRI and over 400 publications on quantitative MT-MRI indexed in PubMed since 1988. 
1.4 CHEMICAL EXCHANGE SATURATION TRANSFER 
 Chemical exchange saturation transfer (CEST) is a type of magnetization transfer where 
the decrease in water signal is due to the exchange of protons between solute molecules and 
water. Like MT from immobile macromolecules, CEST is most simply described using a two 
pool model with one pool representing the solute protons and the other pool representing the 
water protons. Unlike the protons associated with immobile macromolecules which have a broad 
RF absorption line shape that is approximately centered about water resonance, the solute 
protons have an RF absorption line shape that is narrow and asymmetric with respect to water 
resonance (Figure 1.9). The chemical shifts of some physiologically relevant types of solute 
protons are shown in Figure 1.10. (Zhou and van Zijl 2006) 
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Figure 1.9: The RF absorption spectra of water and a NH solute pool (left) have a much narrower 
bandwidth than that of the broad macromolecular pool describing traditional magnetization 
transfer. Much like traditional MT, saturation is transferred to the water pool, reducing the 
amount of detectable water signal (right). Adapted from Ziv 2013. 
 
 
Figure 1.10: The chemical shifts of common solute protons for CEST-MRI in vivo. Adapted 
from Liu 2013. 
 
 Similar to magnetization transfer from immobile macromolecules, the magnetization of 
the water and solute pools may be described by modified versions of the Bloch equations which 
include exchange terms: 
 
𝑑𝑀𝑥
𝑠
𝑑𝑡
= −Δ𝜔𝑠𝑀𝑦
𝑠 − 𝑅2
𝑠𝑀𝑥
𝑠 − 𝑘𝑠𝑤𝑀𝑥
𝑠 + 𝑘𝑤𝑠𝑀𝑥
𝑤  (1.12) 
 
𝑑𝑀𝑦
𝑠
𝑑𝑡
= Δ𝜔𝑠𝑀𝑥
𝑠 +  𝜔1𝑀𝑧
𝑠 − 𝑅2
𝑠𝑀𝑦
𝑠 − 𝑘𝑠𝑤𝑀𝑦
𝑠 + 𝑘𝑤𝑠𝑀𝑦
𝑤  (1.13) 
 
𝑑𝑀𝑧
𝑠
𝑑𝑡
= −𝜔1𝑀𝑦
𝑠 − 𝑅1
𝑠(𝑀𝑧
𝑠 − 𝑀0
𝑠) − 𝑘𝑠𝑤𝑀𝑧
𝑠 + 𝑘𝑤𝑠𝑀𝑧
𝑤  (1.14) 
 
𝑑𝑀𝑥
𝑤
𝑑𝑡
= −Δ𝜔𝑤𝑀𝑦
𝑤 − 𝑅2
𝑤𝑀𝑥
𝑤 + 𝑘𝑠𝑤𝑀𝑥
𝑠 − 𝑘𝑤𝑠𝑀𝑥
𝑤  (1.15) 
 
𝑑𝑀𝑦
𝑤
𝑑𝑡
= Δ𝜔𝑤𝑀𝑥
𝑤 + 𝜔1𝑀𝑧
𝑤 − 𝑅2
𝑤𝑀𝑦
𝑤 + 𝑘𝑠𝑤𝑀𝑦
𝑠 − 𝑘𝑤𝑠𝑀𝑦
𝑤  (1.16) 
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𝑑𝑀𝑧
𝑤
𝑑𝑡
= −𝜔1𝑀𝑦
𝑤 − 𝑅1
𝑤(𝑀𝑧
𝑤 − 𝑀0
𝑤) + 𝑘𝑠𝑤𝑀𝑧
𝑠 − 𝑘𝑤𝑠𝑀𝑧
𝑤  (1.17) 
where Mi
j
 represent the i
th
 component (x, y, and z) of the magnetization of the j
th
 pool (s = solute, 
w = water); ksw and kws represent the first order exchange rates from the solute pool to the water 
pool and the water pool to the solute pool, respectively; ω1 = γB1 where γ is the gyromagnetic 
ratio and B1 is the magnitude of the applied RF saturation pulse; Δω is defined as ω – ω0 where ω 
is the location of the applied RF saturation field and ω0 = γB0 for external magnetic field strength 
B0; and R2 and R1 are the transverse and longitudinal relaxation rates, respectively, of the water 
pool (w) and solute pool (s). These equations apply when the RF saturation pulse is applied 
along the x-direction. (Zhou, Wilson et al. 2004)  
 The imaging procedure for CEST-MRI is similar to the procedure for MT-MRI; an RF 
saturation pre-pulse is applied immediately prior to image acquisition. As with MT-MRI, fast 
imaging techniques such as echo planar imaging (EPI), fast spin echo, and fast gradient echo 
acquisitions are commonly used to minimize the decay of the transferred magnetization. 
Typically many images are acquired, covering a range of saturation frequency offsets. (Zaiss and 
Bachert 2013) 
As with traditional MT, the CEST effect is displayed graphically as the Z-spectrum. The 
solute pools have narrow RF absorption spectra compared to the immobile macromolecules, 
which provide traditional MT, and the location of these absorption spectra near the water 
resonance introduces asymmetry to the Z-spectra (Figure 1.11a and b).  
The CEST effect is described quantitatively as the asymmetry of the MTR with respect to 
water resonance (Figure 1.11c) at a particular offset frequency, MTRasym(ω), which is defined as: 
 𝑀𝑇𝑅𝑎𝑠𝑦𝑚(𝜔) =
𝑆𝑠𝑎𝑡(−𝜔)−𝑆𝑠𝑎𝑡(+𝜔)
𝑆0
  (1.18) 
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where Ssat(-ω) is the signal intensity with the saturation pulse applied at a frequency offset of –ω, 
Ssat(+ω) is the signal intensity with the saturation pulse applied at a frequency offset of +ω, and 
S0 is the signal intensity in the absence of saturation (Zaiss and Bachert 2013). Another 
commonly used method of quantifying the CEST effect is the CEST ratio or CESTR, which is 
defined as: 
 𝐶𝐸𝑆𝑇𝑅(𝜔) =
𝑆𝑠𝑎𝑡(−𝜔)−𝑆𝑠𝑎𝑡(+𝜔)
𝑆𝑠𝑎𝑡(−𝜔)
   (1.19) 
The analysis of asymmetry is based on the assumption that the only two factors 
contributing to the Z-spectrum are DWS and the CEST effect; by calculating asymmetry under 
these conditions, the DWS contribution to the MTR is removed.  
 
Figure 1.11: (a) The 
1
H spectrum, showing a peak for the water pool and smaller solute pool, 
which disappears after saturation and (b) the resulting Z-spectrum, with an apparent asymmetry 
at the location of the solute pool. (c) CEST-MRI is quantitatively analyzed by calculating the 
asymmetry of the Z-spectrum. Adapted from Liu 2013. 
 
Alternatively, one study investigated removing the DWS contribution through Fourier 
transform analysis in a technique called time domain removal of irrelevant magnetization 
(TRIM) rather than calculating MTR asymmetry (Yadav, Chan et al. 2013). In this technique, the 
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MTR as a function of saturation frequency offset is Fourier transformed into the time domain, 
where the signal is fit to a combination of three Lorentzian functions. The portion corresponding 
to DWS is removed from the time domain signal and transformed back into the frequency 
domain, yielding a measure of MTR with the contribution from DWS removed. 
1.5 APPLICATIONS OF CHEMICAL EXCHANGE SATURATION TRANSFER MRI 
The unique contrast mechanism provided by CEST-MRI has a number of potential 
applications, including distinguishing tumor from healthy tissue (Jia, Abaza et al. 2011), 
monitoring change in creatine concentration in skeletal muscle following exercise (Kogan, Haris 
et al. 2014), imaging cartilage based on chemical exchange between glycosaminoglycans and 
water (Singh, Haris et al. 2012), and monitoring breast cancer response to chemotherapy (Dula, 
Arlinghaus et al. 2013). Studies have demonstrated an increased CEST effect in brain tumors, 
and have applied CEST-MRI to distinguish peritumoral edema from white matter and to 
differentiate orthotopic gliomas from radiation induced necrosis (Kogan, Hariharan et al. 2013). 
As of May 2015, there have been 351 publications on CEST-MRI indexed in PubMed. 
1.6 EXTERNAL MAGNETIC FIELD INHOMOGENEITY 
The B0 field inhomogeneity produced by differences in magnetic susceptibility (Section 
1.1.3) shifts MR spectra along the frequency axis, causing the Z-spectrum to shift equivalently 
along the saturation offset frequency axis. In the case of CEST-MRI where the measurements of 
Z-spectral asymmetry are of interest, even small shifts in the positions of Z-spectra can result in 
large changes in asymmetry calculations, rendering them inaccurate unless a B0 inhomogeneity 
correction is applied. Because B0 field inhomogeneity laterally shifts the Z-spectrum by an 
amount proportional to γΔB, the effect can be removed if the magnitude of the B0 field 
inhomogeneity is known (Kim, Gillen et al. 2009). 
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A number of procedures for correcting B0 field inhomogeneity have been demonstrated. 
For sufficiently separated CEST and direct water saturation (DWS) effects, a simple polynomial 
or spline fit is often applied and the minimum of the resulting fit assumed to be the center of the 
Z-spectrum for asymmetry calculations (Zhou, Payen et al. 2003). Another method uses B0 field 
inhomogeneity maps acquired with an appropriate MR acquisition sequence to shift the Z-
spectra; using a gradient echo acquisition with two different echo times, the magnitude of the B0 
field inhomogeneity, ΔB0, is determined from the phase difference between the two images, as 
 Δ𝐵 =
𝜙(𝑇𝐸1)−𝜙(𝑇𝐸2)
𝛾(𝑇𝐸2−𝑇𝐸1)
  (1.20) 
where γ is the gyromagnetic ratio of the proton, TEi are the echo times, and the φ are the 
accumulated phases at each echo time (Haacke, Brown et al. 1999). This procedure has been 
applied to glycosaminoglycan CEST imaging (Wei, Jia et al. 2014). A technique known as water 
saturation shift referencing (WASSR), determines the magnitude of the B0 field inhomogeneity 
effect by collecting a pure DWS image (Kim, Gillen et al. 2009). This is accomplished by 
applying a sufficiently weak RF saturation pre-pulse to minimize interference from both MT and 
CEST effects. Since the resulting DWS is symmetric, the center frequency can be determined by 
reflecting the Z-spectrum about 0 ppm and minimizing the difference between the acquired and 
reflected Z-spectra.  
The points of interest on the Z-spectra for calculating MTR asymmetry are determined by 
the material exhibiting the CEST effect. The Z-spectra are collected at discrete frequency offsets, 
however; MTR asymmetry analysis is performed as a post-processing procedure. After B0 field 
inhomogeneity correction is, the discrete Z-spectral data must be interpolated to calculate the 
MTR asymmetry values. Interpolation is commonly performed by fitting the Z-spectral data with 
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high order polynomials (Jia, Abaza et al. 2011). Other studies have investigated fitting with 
multiple Lorentzian functions with interaction cross-terms for multiple solute pools (Sun 2010).  
1.7 PROSTATE CANCER AND MRI 
In the United States, one in seven men is expected to develop prostate cancer during their 
lifetimes. In 2015, there will be an estimated 220,800 new cases of prostate cancer and more than 
27,500 related deaths, accounting for more than 25% of cancer incidences and 8.8% of cancer 
related deaths in men (Siegel, Miller et al. 2015).  
MRI often aids in the diagnosis and management of prostate cancer. Currently, multi-
parametric techniques are used including T1- and T2- weighted MRI, diffusion weighted MRI, 
dynamic contrast-enhanced MRI, and MR spectroscopic imaging (Langer, van der Kwast et al. 
2009, Hoeks, Barentsz et al. 2011). 
1.8 BLADDER CANCER AND MRI 
There are expected to be 74,000 new cases of bladder cancer and 16,000 related deaths in 
the United States in 2015. Bladder cancer is three times more common in men than in women, 
and is expected to account for 7% of all cancers in men and 4% of cancer deaths in men (Siegel, 
Miller et al. 2015).  
Multi-parametric MRI techniques are often performed to aid in the management of 
bladder cancer. Contrast enhanced and diffusion weighted MRI have demonstrated the ability to 
identify muscle invasion with high accuracy (Green, Durand et al. 2012). These techniques also 
may find applications in evaluating and predicting response to chemotherapy (Nguyen, Jia et al. 
2015).  
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1.9 MOTIVATION FOR RESEARCH 
Currently, CEST-MRI has no universally applied method of data analysis. Z-spectral data 
are interpolated following B0 correction using a variety of methods. This lack of standard 
procedure hinders comparison of results across multiple sites and studies, limiting the adoption 
of MTRasym calculations as a clinically relevant quantitative imaging biomarker. Additionally, no 
standard CEST-MRI phantoms exist to assess the performance of analysis procedures and 
acquisition pulse sequences. The goal of this work was to evaluate curve fitting methods for Z-
spectral data analysis that are based to varying degrees on the physics of CEST-MRI. 
Additionally, this work is to demonstrate the capability of MTRasym calculations based on a 
selected model to distinguish tumor from healthy tissue. 
1.10 HYPOTHESIS AND SPECIFIC AIMS 
The hypothesis of this work was that independently fitting the upfield and downfield 
components of the Z-spectrum with a partially physics-based model will be preferred to fitting 
with high order polynomials based on the quality of fit. Quality of fit was assessed with both 
phantom and prostate MR images. The best quality method was used to calculate MTRasym 
values.  
Aim 1: Compare the quality of fits between a separate upfield and downfield fitting 
procedure and high order polynomial fitting procedure for a CEST-MRI phantom. A CEST-MRI 
phantom was designed, built, and imaged. Z-spectral data were extracted from these images and 
fit using a method with separate upfield and downfield components, as well as two high order 
polynomial models. The small sample bias-corrected Akaike’s Information Criterion (AICc) was 
calculated for each fitting procedure and used to identify a preferred method of curve fitting for 
the phantom images.  
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Aim 2: Compare the quality of fits between the separate upfield and downfield fitting 
model and high order polynomial fitting models for CEST-MRI images of prostate cancer 
patients. Z-spectral data were extracted from images of prostate cancer patients in different 
regions of the prostate. The Z-spectral data were fit with a subset of the models tested in Aim 1. 
The quality of these fits was compared using the small sample bias-corrected AICc, identifying a 
preferred method of curve fitting for the patient images. 
Aim 3: Apply the model to images of bladder cancer patients, and calculate the MTRasym 
values to demonstrate capability of the model. Z-spectral data were extracted from images of 
bladder cancer patients and fit using the preferred method of curve fitting identified in Aims 1 
and 2. The Z-spectral fits were used to calculate MTRasym values in the different regions of the 
phantom to demonstrate that the measures of MTRasym have the ability to distinguish bladder 
cancer from normal bladder tissue. 
1.11 OVERVIEW OF THE THESIS 
The specific aims were used to demonstrate the efficacy of separately fitting the Z-
spectral components upfield and downfield from water resonance. Specifically, a preferred 
method of curve fitting was identified using the AICc for both phantom images and prostate 
cancer patient images, and this preferred method was applied to bladder cancer patient images to 
demonstrate the utility of the preferred model. 
Chapter 2 explains the methods and procedures used to test the hypothesis that fitting the 
upfield and downfield components of the Z-spectra separately is preferable to fitting with a high 
order polynomial, based on a combination of parametric parsimony and discrepancy between the 
Z-spectral data and the fitting model. These methods and procedures include details regarding 
the design and construction of the phantom, as well as the prostate cancer patient imaging 
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technique. Chapter 2 also details the procedure of demonstrating the utility of the model by 
distinguishing healthy bladder tissue from tumor with these measurements. 
Chapter 3 details the results of phantom development as well as comparison of fitting 
models. The preferred model for Z-spectral fitting was identified from the phantom study and the 
retrospective patient study. Additionally, MTRasym measurements made using the preferred 
model were applied to assess their ability to distinguish bladder cancer from healthy bladder 
tissue. 
Chapter 4 discusses the results, including the strengths and limitations of this work. This 
chapter also includes a recommendation for future research directions based upon the outcomes 
presented here. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Z-SPECTRAL CURVE FITTING METHOD – OVERVIEW 
This study proposed a model which separately fits the upfield and downfield components 
of the Z-spectra obtained in CEST-MRI experiments (Figure 2.1). The effects of DWS, MT, and 
the Nuclear Overhauser Effect (NOE) are observed in the region of the Z-spectrum upfield from 
water resonance. The effects of DWS, MT, and CEST are expected to be observed in the 
downfield region of the Z-spectrum. 
 
Figure 2.1: A sample Z-spectrum (open circles). Downfield from water, DWS, MT, and CEST 
effects are expected, while upfield from water DWS, MT, and NOE effects are expected. The 
DWS and MT components of this Z-spectrum are plotted and labeled. 
 
The contribution from NOE is usually neglected in CEST-MRI measurements performed 
at a field strength of 3 T, although it can become significant at higher field strengths; a term can 
be added to account for NOW. NOE was not included in this work. A Lorentzian function was 
used to describe DWS (Zaiß, Schmitt et al. 2011), and a function was chosen for MT depending 
upon the material (Sections 2.1.1 and 2.1.2). 
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 The downfield component of the Z-spectrum could potentially be modeled based on the 
different effects which are present, similar to the upfield component. For instance, using a sum of 
Lorentzian functions describing different solute pools with exchange terms could describe the 
downfield component, including the CEST contribution (Sun 2010). In tissue, however, the 
many different types of solute protons have overlapping regions of RF absorption, resulting in an 
excessive number of fitting parameters relative to the available number of data points. To avoid 
this, a polynomial was used to fit the downfield component.  
These models combining the upfield and downfield components were referred to as the 
“combination model” in this work. The models were identified by the order of polynomial used 
to fit the downfield region of the Z-spectrum. For example, “6th order combination” would refer 
to fitting the upfield region with the DWS and MT components (see Equation 2.1 or Equation 
2.2) and the downfield region with a 6
th
 order polynomial. 
2.1.1 Z-SPECTRAL CURVE FITTING METHOD - PHANTOM 
Previous studies demonstrated that Gaussian functions appropriately describe the MT 
effect in agar (Morrison and Henkelman 1995). In Aim 1, MT in the phantom was provided by 
agar, so the upfield components of the Z-spectra was fit to: 
 
𝑆
𝑆0
= 1 −
𝐴𝑤(
𝐺𝑤
2
)
2
(
𝐺𝑤
2
)
2
+Δ𝜔2
− 𝐴𝑏 exp [− (
1
2
) (
𝛥𝜔
𝐶𝑏
)
2
]  (2.1) 
where Aw and Gw were the magnitude and full width at half maximum (FWHM), respectively, of 
the Lorentzian describing DWS, Δω was the frequency offset from water resonance, Ab was the 
magnitude of MT, and Cb was a constant, determined through curve fitting, describing the width 
of the Gaussian function used  to describe MT in agar. 
 The downfield region was fit to polynomial functions, the orders of which are discussed 
in Section 2.3.5. 
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2.1.2 Z-SPECTRAL CURVE FITTING METHOD - PATIENT 
Although it has been demonstrated that super-Lorentzian functions are a good description 
of MT in tissue, they are very broad relative to DWS and may be treated as constants in a small 
range near water resonance. In Aims 2 and 3, MT is provided by the relatively immobile 
macromolecules in tissue, so the upfield components of the Z-spectra were fit to: 
 
𝑆
𝑆0
= 1 −
𝐴𝑤(
𝐺𝑤
2
)
2
(
𝐺𝑤
2
)
2
+Δ𝜔2
− 𝐴𝑏  (2.2)  
where Aw and Gw were the magnitude and FWHM, respectively, of the Lorentzian describing 
DWS, Δω was the frequency offset from  water resonance, and Ab was the magnitude of MT. 
2.2 MODEL SELECTION CRITERIA 
The preferred fitting model was identified using the small sample bias-corrected Akaike 
Information Criterion (AICc). The AICc compares the quality of proposed fitting models for a 
set of data, with the preferred model having the most negative AICc value (Hurvich and Tsai 
1989). The AICc is calculated based on the residual sum of squares (RSS), the sample size (n), 
and the number of fitting parameters in the proposed model (m), according to the equation: 
 𝐴𝐼𝐶𝑐 = 𝑛 ln (
𝑅𝑆𝑆
𝑛
) + 𝑛
1+𝑚/𝑛
1−(𝑚+2)/𝑛
  (2.3) 
The AICc value was computed in IDL (Version 8.2, Exelis Visual Information Solutions) 
for each of the models tested following the curve fitting procedure. A pairwise Student’s t-test 
was performed in the statistical analysis software R (Version 3.1.0, R Development Core Team) 
to determine if the average AICc values were statistically significantly different for the models. 
The preferred model will be identified as having the most negative average AICc; in cases where 
two models did not have significantly different average AICc values, the most negative 
maximum AICc was used.   
22 
 
2.3 AIM 1, APPLICATION OF MODEL TO CEST-MRI PHANTOM IMAGES 
2.3.1 PHANTOM MATERIAL SELECTION 
To create a CEST-MRI phantom, materials were selected with RF absorption covering a 
range of offset frequencies. The materials and their offset frequencies are listed in Table 2.1. All 
of the materials were incorporated in 2% agar to provide a broad MT effect due to immobile 
macromolecules, allowing the phantom to exhibit CEST effects in the presence of MT to mimic 
the situation that would be seen in vivo. Additionally, the agar was prepared with 0.01 M 
phosphate-buffered saline (PBS) with a pH of 7.4 to represent physiological. Three 
concentrations (Table 2.1) were selected for each material, either to match concentrations that 
have been used previously in literature or to use concentrations that are representative of 
physiological conditions. 
Table 2.1: Concentrations of materials included in the CEST-MRI phantom and the 
corresponding frequency offset at which the CEST effects are expected. 
 Material
ref
 Concentration A 
[mM] 
Concentration B 
[mM] 
Concentration C 
[mM] 
Frequency Offset 
[ppm] 
1 *Glycogen
1,2 
10 50 100 1.2 
2 *Glucose
2 
10 50 100 1.3 - 2 
3 *Creatine
3 
10 25 50 1.8 
4 *L-Lysine
4 
1 10 100 3.0 
5 *NH4Cl
5 
100 500 1000 2.4 
6 *Choline
6 
5 15 50 1.0 
7 Agar
5 
2% 4% 6% MT 
* indicates the material was mixed in 2% agar. 
1 Taylor 1996 
2 van Zijl 2007 
3 Kogan 2014 
4 Ward 2000 
5 Desmond 2012 
6 Chen 2006 
 
2.3.2 PHANTOM DEVELOPMENT 
The selected materials were built into an existing MRI phantom (model MRI-R01, Data 
Spectrum Corporation, Durham, NC, USA). This cylindrical, water-filled phantom (Figure 2.2) 
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included plastic inserts which held twenty-one vials of 30 mL total volume each. The vials were 
separated into three groups of seven, shown in Figure 2.2 (right) and Figure 2.3. 
 
Figure 2.2: The Data Spectrum Corporation's MRI phantom. The phantom includes inserts for 
spatial resolution, slice thickness, slice profile, linearity, and quantitative imaging (left), though 
only the quantitative imaging insert (right) is of interest to this study. 
 
  
Figure 2.3: The layout of vials in the CEST phantom. Numbers 1-6 correspond to the materials 
as numbered in Table 2.1, while the letters A, B, and C identify the low concentrations, 
intermediate concentrations, and high concentrations, respectively. Vial 7 in each group 
contained agar alone in concentrations of 2% (7A), 4% (7B), or 6% (7C). 
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Each group of vials contained all six of the materials; one group was the lowest 
concentrations, one was the intermediate concentrations, and one was the highest concentrations. 
In each group, the vial closest to the central axis of the phantom was glycogen, with the 
remaining materials placed counterclockwise in the order of glucose, creatine, L-lysine, NH4Cl, 
and choline (Figure 2.3). The central vial of each group contained the agar with a concentration 
of 2%, 4%, or 6%; the relative concentrations corresponded to the relative material 
concentrations, so that the groups could be identified by the magnitude of the MT effect in the 
agar vials. 
The vials were glass liquid scintillation vials. The vials were filled with 0.36 g of 
powdered agar, 0.11 g of 5% w/v NaN3 as an antibacterial agent (Hattori, Ikemoto et al. 2013), 
and the required mass of material to meet the concentrations listed in Table 2.1. These were 
mixed in PBS to a final mass of 18 g. Each mixture was heated in a water bath at 90°C for 20 
minutes; the mixture was stirred halfway through the heating period. After heating, the mixtures 
were stirred again; the vials were capped and placed on ice to solidify.    
2.3.3 PHANTOM IMAGING PROCEDURE 
T1-weighted and T2-weighted images were acquired to assess the properties of the 
phantom. The images were acquired using a 4 channel head coil on a 3 T MR system (Signa, GE 
Healthcare, Waukesha, WI). T1 mapping was performed using an inversion recovery technique. 
Images were acquired with a fast spin echo pulse sequence with the following sequence 
parameters: a TE of 15 ms; a TR of 7500 ms; multiple TIs of 1900 ms, 1600 ms, 1300 ms, 800 
ms, 600 ms, and 500 ms; an echo train length of 16; receiver bandwidth of 50 kHz; a FOV of 30 
× 30 cm
2
; a slice thickness of 10 mm; a NEX of 1; acquisition matrix of 256 × 256; and the 
frequency encoding direction R/L. Post-processing for the T1 map was performed using the 
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MRMap software (Version 1.4, Daniel Messroghli) written in IDL (Figure 2.4) and freely 
available for download online (http://sourceforge.net/projects/mrmap/).  
T2 measurements were made using a multiple echo time technique from images acquired 
with a fast spin echo pulse sequence with the following sequence parameters: TEs of 7.3 ms, 
14.2 ms, 21.3 ms, 28.5 ms, 35.6 ms, 42.7 ms, 49.8 ms, and 56.9 ms; a TR of 1650 ms; a receiver 
bandwidth of 62.25 kHz; a FOV of 30 × 30 cm
2
; a NEX of 1; an acquisition matrix of 320 × 256; 
and a frequency encoding direction of R/L. Post-processing for the T2 calculations was 
performed using the Dynamic Magnetic Resonance Imaging Software Tool (Version OSU-5.0, 
Division of Imaging Research, The Ohio State University) written in IDL (Figure 2.5). 
 
Figure 2.4: The software MRMap (Version 1.4, Daniel Messroghli) was used to create T1 maps, 
performing the required curve fitting for each pixel. 
 
For CEST-MR imaging, the phantom was imaged on a 3 T MR system (Achieva, Philips 
Healthcare, Cleveland, OH) using a 32 channel digital head coil. Images were acquired using a 
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2D multiple-shot turbo spin echo sequence (msTSE) with a TR of 3000 ms, TE of 26 ms, slice 
thickness of 6 mm, acquisition matrix size of 112 × 100, field of view of 225 × 225 mm
2
, TSE 
factor of 20, NSA of 1, and flip angle of 90˚. A train of RF saturation pre-pulses consisting of 16 
block pulses each 29 ms in length was applied at frequency offsets from 8 ppm to -8 ppm in 0.5 
ppm increments. An additional image was acquired without saturation as a reference. A set of 
CEST-MR images was acquired for each of the following saturation amplitudes: 1.6 µT, 2.4 µT, 
3.2 µT, and 4.0 µT. 
 
Figure 2.5: The Dynamic Magnetic Resonance Imaging Software Tool (Version OSU-5.0, 
Division of Imaging Research, The Ohio State University) was used to calculate T2 values in 
user-defined regions of the phantom. 
 
B0 field inhomogeneity maps were collected after CEST-MR imaging using a 2D fast 
field echo (FFE) technique with the following sequence parameters: a TR of 15 ms; ΔTEs of 1 
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ms, 3 ms, 5 ms, 7 ms, and 9 ms; a slice thickness of 6 mm; an acquisition matrix size of 112 × 
112; a field of view of 225 × 225 mm
2
; NSA of 1; and a flip angle of 8˚. Reconstruction was 
performed automatically with the MR system software. 
2.3.4 Z-SPECTRAL DATA COLLECTION 
The Dynamic Magnetic Resonance Imaging Software Tool was used to extract the Z-
spectral data from the CEST-MR images of the phantom. ROIs were placed in the center of each 
of the 21 materials with margins large enough to avoid any pixels containing the glass walls of 
the liquid scintillation vials. For each of the saturation amplitudes, the average signal intensity in 
each region collected for the 33 CEST-MR images, as well as the average signal intensity in the 
absence of saturation and the average B0 field inhomogeneity. 
 2.3.5 Z-SPECTRAL CURVE FITTING 
Prior to fitting the Z-spectral data, the frequency axis coordinates were corrected for B0 
inhomogeneity by subtracting the average B0 value (in ppm) from the acquired frequency offsets 
(8 ppm to -8 ppm in 0.5 ppm increments). This corrected the lateral shift of the Z-spectra due to 
the B0 field inhomogeneity. 
The indices of the B0-corrected positive and negative frequency offsets were then 
identified. Data points with negative frequency offsets were fit to Equation 2.2. When 
subsequently fitting the downfield (positive) frequency offsets, the fitted zero-frequency value 
from the upfield fit was included with the downfield offset data. Including this fitted upfield 
value in the downfield fit caused the upfield and downfield fits to meet at the 0 ppm frequency 
offset. 
Z-spectral fitting was performed in IDL using the nonlinear least squares curve fitting 
package MPFIT (Markwardt 2009). Two models from literature, a 20
th
 order polynomial and a 
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12
th
 order polynomial, were fit to Z-spectral data for each ROI. The combination model proposed 
in Section 2.1 was fit with downfield polynomials of 3
rd
, 4
th
, 5
th
, 6
th
, 7
th
, and 8
th
 orders to 
determine the preferred degree. Data points with signal intensities less than 5% of the signal in 
the absence of saturation occurred near the center of the Z-spectra, and were not included in the 
fitting procedure because of the poor signal-to-noise ratio of this data. For each of the 8 models 
applied, the AICc was calculated from the fitted Z-spectra in IDL using Equation 2.3. 
2.3.6 ASSESSMENT OF MODEL PERFORMANCE 
 Performance of the models was assessed using the AICc values calculated after the curve 
fitting process. The preferred curve fitting model produced the most negative average AICc 
value. 
2.4 AIM 2, APPLICATION OF MODEL TO PROSTATE CANCER PATIENT IMAGES 
2.4.1 PROSTATE CANCER PATIENT POPULATION 
Eighteen patients with biopsy-proven prostate cancer were included in this retrospective 
study. Thirteen of these patients underwent prostatectomy, while five received radiation therapy. 
An additional two volunteers were included. The average age of those enrolled in the study was 
61.1 years (range, 51 to 76). Tumor staging information was available from final pathology 
reports for the 13 patients who underwent prostatectomy; the distribution of these tumor stages 
was: two T2a, one T2b, seven T2c, and three T3a. The study was approved by an institutional 
review board (IRB) at The Ohio State University and was compliant with the Health Insurance 
Portability and Accountability Act (HIPAA). Informed consent was obtained from each patient.  
2.4.2 PROSTATE CANCER PATIENT IMAGING 
All MR images were acquired with a 3 T MR system (Achieva, Philips Healthcare) using 
a 32 channel phased array coil. Images were selected based on the location of the tumor within 
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the prostate; CEST-MRI images were acquired using a single slice, single-shot turbo spin echo 
(ssTSE) pulse sequence with a TR of 4000 ms, TE of 56 ms, slice thickness of 6 mm, acquisition 
matrix size of 80 × 65, field of view of 140 × 140 mm
2
, TSE factor of 64, NSA of 1, and flip 
angle of 90˚. The RF saturation pre-pulse consisted of sixteen block pulses 31 ms in duration 
with saturation amplitudes of 1.6 µT, 2.4 µT, 3.2 µT, and 4.0 µT. For each of the saturation 
amplitudes, 33 images were acquired with the saturation pre-pulse applied at offset frequencies 
from 8 ppm to -8 ppm in 0.5 ppm increments. An additional image was acquired without 
saturation as a reference. The acquisition time for this process was 3.5 minutes. Additionally, a 
B0 map was obtained for each patient using a 2D fast field echo (FFE) sequence with a TR of 48 
ms, TE1 of 1.58 ms, TE2 of 4.1 ms, slice thickness 6 mm, acquisition matrix of 80 × 65, field of 
view of 140 × 140 mm
2
, NSA of 6, flip angle of 20˚, and acquisition time of 19.5 s. The B0 map 
was created using the scanner’s automatic reconstruction. 
2.4.3 PROSTATE CANCER PATIENT Z-SPECTRAL DATA COLLECTION 
Pathology slides were created from tissue samples from patients who underwent 
prostatectomy. Experienced uropathologists identified the location and extent of the tumors. The 
slides were digitized to create images that could be co-registered with MR images, and regions of 
interest (ROIs) for the peripheral zone (PZ), central gland (CG), and tumor were created by an 
experienced medical physicist. Patients receiving radiation therapy had ROIs delineated by the 
physicist based on T2-weighted imaging and biopsy reports. An example of a pathologic slide 
with the marked tumor location and the resulting tumor ROI overlaid onto the CEST-MR image 
is shown in  Figure 2.6.  
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Figure 2.6: The pathologic slide created by the uropathologist (a) and the corresponding ROI 
drawn in the CEST-MR image (b). 
 
Z-spectral data were extracted from the 232 resulting ROIs using the Dynamic Magnetic 
Resonance Imaging Software Tool. The average signal intensities for each of the 33 CEST-MR 
images, and the image in the absence of saturation, were recorded. The average B0 value from 
the B0 map was recorded.  
2.4.4 Z-SPECTRAL CURVE FITTING 
Prior to fitting the Z-spectral data, B0 field inhomogeneity correction was performed. Z-
spectral fitting was performed in as described in Section 2.3.5. The 20
th
 and 12
th
 order 
polynomials were used to fit the complete set of Z-spectral data. The combination models were 
fit with downfield polynomials of 3
rd
, 4
th
, 5
th
, and 6
th
 order. These orders were selected based on 
the phantom results (see Section 3.1.3).  
2.4.5 ASSESSMENT OF MODEL PERFORMANCE 
 Performance of the models was assessed using the AICc values calculated after curve 
fitting. The curve fitting model providing the most negative average AICc values was identified. 
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2.5 AIM 3, APPLICATION OF MODEL TO BLADDER CANCER PATIENT IMAGES 
2.5.1 BLADDER CANCER PATIENT POPULATION 
25 patients (19 male, 6 female) with biopsy-proven bladder cancer were enrolled in this 
study. The patients had an average age at the time of baseline imaging of 64 years (standard 
deviation, 12 years), and an average weight of 83.7 kg (standard deviation, 19.3 kg). The study 
was approved by an IRB at The Ohio State University and was HIPAA compliant. Informed 
consent was obtained from each patient. 
2.5.2 BLADDER CANCER PATIENT IMAGING 
The patients were imaged on a 3 T MR system (Achieva, Philips Healthcare) using a 32 
channel cardiac surface coil. Images were acquired with a single-shot TSE sequence with the 
following parameters: a TR of 6100 ms; a TE of 56 ms; a TSE factor of 47; a NSA of 1; an 
acquisition matrix of 80 × 65; a FOV of 140 × 140 mm
2
; a slice thickness of 6 mm; and a flip 
angle of 90˚. The acquired slice was positioned to include the tumor with the aid of T2-weighted 
anatomical images. The saturation pre-pulse consisted of 16 block pulses each 29 ms in duration 
with a saturation amplitude of 4.0 µT; 33 CEST-MR images were acquired with the saturation 
pre-pulse applied at frequency offsets from 8 ppm to -8 ppm in 0.5 ppm increments. An 
additional image was acquired in the absence of saturation. The acquisition time for the CEST-
MR images was 3.5 minutes. A B0 field inhomogeneity map was acquired using a dual echo FFE 
technique with the following sequence parameters: a TR of 69.6 ms; TE of 2 ms and 10 ms; a 
NSA of 4; an acquisition matrix of 80 × 65; a FOV of 140 × 140 mm
2
; a slice thickness of 6 mm; 
and a flip angle of 20˚. The acquisition time was 25 seconds. Reconstruction was performed 
automatically by the MR system software. 
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2.5.3 Z-SPECTRAL DATA COLLECTION 
For each bladder cancer patient, ROIs for normal bladder wall (NBW) and tumor were 
delineated based on anatomical T2-weighted images by an experienced medical physicist. The Z-
spectral data in each ROI, including the average B0 value from the field inhomogeneity map, 
were collected with the Dynamic Magnetic Resonance Imaging Software Tool.  
2.5.4 Z-SPECTRAL CURVE FITTING 
Prior to curve fitting, the B0 inhomogeneity correction discussed in previous sections was 
applied. The upfield component was fit to Equation 2.1, and the downfield component was fit to 
a 4
th
 order polynomial, which was determined to be the preferred Z-spectral curve fitting model 
for phantom images with a saturation amplitude of 4.0 µT (see Section 3.2 and Section 4.4). Data 
points were excluded from the fitting process if the signal average at that frequency offset was 
less than 5% of the signal intensity in the absence of saturation, to avoid data points with a low 
signal-to-noise ratio. 
2.5.5 DISTINGUISHING NORMAL BLADDER WALL FROM CANCER 
The shifted, fitted Z-spectra were used to calculate MTRasym at frequency offsets of 2.0 
ppm and 3.5 ppm, corresponding to the amine and amide protons, respectively. A two-tailed, 
paired Student’s t-test was used to test for significant differences in the MTRasym(2.0 ppm) and 
MTRasym(3.5 ppm) quantities between the NBW and tumor regions. A Shapiro-Wilk test was 
performed to confirm that the data was normally distributed. These tests were performed using 
the statistical analysis software, R (Version 3.1.0, R Development Core Team). P-values less 
than 0.05 were considered significant for all tests.  
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CHAPTER 3: RESULTS 
3.1 RESULTS FOR AIM 1: PHANTOM MODEL SELECTION 
3.1.1 PHANTOM PROPERTIES 
 Average values for T1 and T2 relaxation times and the associated standard deviations and 
standard errors are contained in Table 3.1. Standard deviations for T1 are the standard deviation 
of pixel values from the T1 map, while standard errors for T2 measurements are from the 
Dynamic Magnetic Resonance Imaging Software Tool. 
Table 3.1: Average T1 and T2 relaxation times and the associated standard deviations (σT1) or 
standard errors (SET2) for the regions of the phantom. Table 2.1 contains the concentration 
values for A, B, and C. 
Material Concentration T1 (ms) σT1 (ms) T2 (ms) SET2 (ms) 
Agar  A 2360 170 136 6 
B 1910 540 66 2 
C 1710 120 56 2 
Choline  A 2370 140 125 7 
B 2410 150 136 6 
C 2410 170 145 6 
Creatine A 2500 300 190 13 
B 2340 160 153 6 
C 2550 430 167 17 
Glucose A 2410 150 146 6 
B 2320 120 115 5 
C 2350 150 112 4 
Glycogen A 2410 120 131 8 
B 2240 110 121 5 
C 2060 390 114 4 
Lysine A 2400 310 129 2 
B 2370 260 115 7 
C 2480 660 154 27 
NH4Cl A 2480 210 130 6  
B 2630 420 101 6 
C 2660 605 99 8 
Water  2960 180 1030 520 
  
The B0 field inhomogeneity maps are shown in Figure 3.1. The measured B0 field 
inhomogeneity increased with increasing difference in echo times. The B0 field inhomogeneity 
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map with a ΔTE of 5 ms was used for the CEST-MR image post processing because it was the 
largest echo time difference that did not produce noticeable artifacts due to large phase 
differences. 
 
Figure 3.1: The B0 field inhomogeneity maps created with echo time differences of (a) 1 ms, (b) 
3 ms, (c) 5 ms, (d) 7 ms, and (e) 9 ms. A phase wrapping artifact is evident for echo time 
differences of 7 ms and 9 ms. 
 
3.1.2 PHANTOM CURVE FITTING RESULTS 
 Representative examples of the curve fitting results for CEST-MR Z-spectra with a 
saturation amplitude of 1.6 µT are shown in Figure 3.2. The Z-spectra from a low saturation 
amplitude were more sharply peaked than those from higher saturation amplitudes. This caused 
the combination models using low order polynomials to perform poorly visually in the region of 
the Z-spectrum upfield from water resonance, indicated by the arrow in Figure 3.2a. The 
combination models using higher order polynomials perform well visually, though the 8
th
 order 
combination model shows some oscillation near the end of the fitting interval, indicated by the 
arrow in Figure 3.2b. The two polynomial models both experience significant oscillation near the 
ends of the fitting intervals, indicated by the arrows in Figure 3.2c and Figure 3.2d.  
 Representative examples of the curve fitting results for CEST-MR Z-spectra with a 
saturation amplitude of 4.0 µT are shown in Figure 3.3. At this high saturation amplitude, the Z-
spectra became less sharply peaked. The broader shape of the Z-spectra decreased the size of the 
oscillations near the edges of the interval for all models, and in many cases eliminated all 
oscillations. The visual performance of the combination model using a low order polynomial 
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improved as the saturation amplitude increased, as shown by the difference between Figure 3.2a 
and Figure 3.3a. In some cases, the combination models using high order polynomials had large 
deviations from the expected shape due to the excluded data points around 0 ppm, indicated by 
the arrow in Figure 3.3b. The 12
th
 order polynomial performed well visually at this high 
saturation amplitude, shown in Figure 3.3c. The 20
th
 order polynomial exhibited oscillations 
even at this high saturation amplitude, shown in Figure 3.3d.  
 
Figure 3.2: The Z-spectrum for Glucose concentration C with a saturation amplitude of 1.6 µT fit 
with (a) the 3
rd
 order combination model, (b) the 8
th
 order combination model, (c) the 12
th
 order 
polynomial model, and (d) the 20
th
 order polynomial model. 
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Figure 3.3: The Z-spectrum for Glucose concentration C with a saturation amplitude of 4.0 µT fit 
with (a) the 3
rd
 order combination model, (b) the 8
th
 order combination model, (c) the 12
th
 order 
polynomial model, and (d) the 20
th
 order polynomial model. 
 
3.1.3 PHANTOM MODEL SELECTION 
 The distributions of AICc values for the Z-spectra with a saturation amplitude of 1.6 µT 
are displayed as boxplots in Figure 3.4. The average AICc values are listed in Table 3.2, ordered 
by increasing average AICc. The combination models utilizing low order polynomials did not 
perform well at this saturation amplitude using the AICc as a metric due to a high residual sum 
of squares. The large AICc of the high order polynomial fitting was due to the large number of 
fitting parameters rather than the goodness of fit. The 6
th
 order combination was the preferred 
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model for the 1.6 µT saturation amplitude as it has the most negative maximum AICc of the 
subset of models with the most negative but statistically indistinguishable average AICc. 
 
Figure 3.4: The distributions of AICc values averaged over all material concentrations with the 
saturation amplitude of 1.6 µT. The averages indicated on the boxplots are median values. * 
indicates the preferred model. 
 
Table 3.2: AICc results of the models for the saturation amplitude of 1.6 µT, ordered by 
increasing average AICc.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 6
th
 order -263.0 24.3 -317.4 -229.9 
2 Combination, 7
th
 order -261.5 24.6 -316.2 -224.0 
3 Combination, 8
th
 order -261.4 23.7 -310.8 -223.9 
4* Combination, 5
th
 order -240.9 17.1 -279.6 -210.1 
5** Polynomial, 12
th
 order -200.7 23.5 -248.4 -169.1 
6** Combination, 4
th
 order -190.8 16.6 -240.1 -174.1 
7** Combination, 3
rd
 order -158.7 12.0 -197.7 -148.5 
8** Polynomial, 20
th
 order -133.9 32.2 -184.9 -49.9 
* indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
 
 The distributions of AICc values for the Z-spectra with a saturation amplitude of 2.4 µT 
are displayed as boxplots in Figure 3.5. The average AICc values for each model and the 
associated standard deviations, minimums, and maximums are listed in Table 3.3. The 4
th
 and 5
th
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order combination models showed lower average AICc compared to the 1.6 µT saturation 
amplitude Z-spectra, with the 5
th
 order combination having the most negative average AICc. As 
with the 1.6 µT saturation amplitude, the poor performance of the 20
th
 order polynomial model 
was due to the large number of fitting parameters relative to the number of data points, while the 
poor performance of the 3
rd
 order combination model was due to the relatively high sum of 
squared residuals. The 5
th
 order polynomial model was the preferred model for the 2.4 µT 
saturation amplitude because it had the most negative maximum AICc of the subset of models 
with the most negative but statistically indistinguishable average AICc. 
 
Figure 3.5: The distributions of AICc values averaged over all material concentrations with the 
saturation amplitude of 2.4 µT. The averages indicated on the boxplots are median values. * 
indicates the preferred model. 
 
 The distributions of AICc values for Z-spectra with a saturation amplitude of 3.2 µT are 
displayed as boxplots in Figure 3.6. The average AICc values for each model are listed in Table 
3.4. The relatively large saturation amplitude improved the performance of the combination 
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model relying on the lower order polynomials to fit the region of the Z-spectra upfield from 
water resonance. The average AICc values for the 20
th
 order polynomial continued to increase as 
more data points fell below the exclusion threshold for the fitting procedure which further 
increased the ratio of fitting parameters to the number of data points.  The 6
th
 order combination 
model was the preferred model for the 3.2 µT saturation amplitude because it had the most 
negative maximum AICc of the subset of models with the most negative but statistically 
indistinguishable average AICc. 
Table 3.3: AICc results of the models for the saturation amplitude of 2.4 µT, ordered by 
increasing average AICc.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 5
th
 order -248.3 20.1 -282.1 -217.8 
2 Combination, 6
th
 order -246.2 20.4 -279.8 -212.1 
3 Combination, 7
th
 order -245.8 20.1 -277.5 -205.2 
4* Combination, 8
th
 order -241.3 20.9 -273.6 -199.7 
5** Polynomial, 12
th
 order -235.0 21.5 -273.9 -176.1 
6** Combination, 4
th
 order -227.5 10.5 -246.5 -206.9 
7** Combination, 3
rd
 order -175.3 16.0 -232.9 -160.9 
8** Polynomial, 20
th
 order -79.2 34.9 -168.4 -12.0 
* indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
 
The distributions of AICc values for the Z-spectra with a saturation amplitude of 4.0 µT 
are displayed as boxplots in Figure 3.7. The average AICc values for each model are listed in 
Table 3.5. The performance of the combination models using low order polynomials improved 
further at the large saturation amplitude, with the 5
th
 order combination model having the most 
negative average AICc value and the 4
th
 order combination having the most negative maximum 
AICc value. The AICc values for the 20
th
 order polynomial continued to increase with increasing 
saturation amplitude as more data points fell below the exclusion threshold and the ratio of 
fitting parameters to data points increased further. The 4
th
 order combination was the preferred  
40 
 
model because there was no significant difference (p > 0.05) between the average AICc value for 
the 4
th
 order combination and 6
th
 order combination models, but the 4
th
 order combination model 
had the most negative maximum AICc value. 
 
Figure 3.6: The distributions of AICc values averaged over all material concentrations with the 
saturation amplitude of 3.2 µT. The averages indicated on the boxplots are median values. * 
indicates the preferred model. 
 
Table 3.4: AICc results of the models for the saturation amplitude of 3.2 µT, ordered by 
increasing average AICc.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 6
th
 order -237.3 17.1 -264.3 -200.7 
2 Combination, 7
th
 order -236.4 21.0 -275.4 -194.8 
3 Combination, 4
th
 order -233.9 16.1 -253.5 -198.5 
4 Combination, 5
th
 order -230.6 15.9 -260.8 -196.4 
5 Combination, 8
th
 order -230.6 22.3 -275.3 -186.9 
6 Polynomial, 20
th
 order -227.5 24.7 -274.7 -176.4 
7** Combination, 3
rd
 order -197.0 16.7 -249.5 -178.1 
8** Polynomial, 20
th
 order -41.9 68.1 -143.0 186.3 
* indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
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Figure 3.7: The distributions of AICc values averaged over all material concentrations with the 
saturation amplitude of 4.0 µT. The averages indicated on the boxplots are median values. * 
indicates the preferred model. 
 
Table 3.5: AICc results of the models for the saturation amplitude of 4.0 µT, ordered by 
increasing average AICc.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 5
th
 order -229.9 23.6 -266.5 -178.7 
2 Combination, 4
th
 order -229.3 22.4 -270.3 -184.3 
3 Combination, 6
th
 order -228.1 25.3 -263.4 -173.7 
4 Combination, 7
th
 order -222.3 26.0 -262.1 -168.3 
5 Polynomial, 12
th
 order -221.2 35.9 -291.2 -149.5 
6 Combination, 8
th
 order -215.9 25.2 -254.3 -167.0 
7** Combination, 3
rd
 order -211.5 16.1 -238.2 -179.5 
8** Polynomial, 20
th
 order 105.1 201.3 -53.7 920.3 
* indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
 
 The distributions of AICc values for the combination of all saturation amplitudes are 
displayed as boxplots in Figure 3.8. The average AICc values for the combination of all 
saturation amplitudes are listed in Table 3.6. Although the model with the most negative AICc 
value was the 6
th
 order combination, there was no significant difference (p > 0.05) between AICc 
values for the 5
th
, 6
th
, 7
th
, and 8
th
 order combination models. Because of this, the 5
th
 order 
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combination was identified as the preferred model because it had the most negative maximum 
AICc value of that group of models. 
 
Figure 3.8: The distributions of AICc values for all of the fitting models tested for the CEST-
MRI phantom at all saturation amplitudes. * indicates the preferred model. 
 
Table 3.6: AICc results of the models for all saturation amplitudes, ordered by increasing 
average AICc.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 6
th
 order -243.7 25.2 -317.4 -173.7 
2 Combination, 7
th
 order -241.5 26.8 -316.2 -168.3 
3 Combination, 5
th
 order -237.4 20.5 -282.1 -178.7 
4 Combination, 8
th
 order -237.3 28.1 -310.8 -167.0 
5* Polynomial, 12
th
 order -221.1 29.4 -291.2 -149.5 
6* Combination, 4
th
 order -220.4 24.1 -270.3 -174.1 
7** Combination, 3
rd
 order -185.6 25.3 -249.5 -148.5 
8** Polynomial, 20
th
 order -37.5 139.2 -184.9 920.3 
* indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
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 The preferred model selected by the AICc depended on the amplitude of the saturation  
pre-pulse. Table 3.7 lists the preferred fitting model for each of the saturation amplitudes tested. 
A combination models was preferred for all saturation amplitudes tested, and the order of the 
polynomial used for the portion of the Z-spectrum upfield from water resonance decreased with 
increasing saturation amplitude. 
Table 3.7: The preferred fitting models for the CEST-MRI phantom images as selected by AICc 
for each of the saturation amplitudes tested.  
Saturation Amplitude Preferred Model 
1.6 µT 6
th
 Order Combination 
2.4 µT 5
th
 Order Combination 
3.2 µT 6
th
 Order Combination 
4.0 µT 4
th
 Order Combination 
All Amplitudes 5
th
 Order Combination 
 
3.2 RESULTS FOR AIM 2: MODEL SELECTION WITH PATIENT IMAGES 
3.2.1 PROSTATE CANCER PATIENT CURVE FITTING RESULTS 
 A representative sample of the curve fitting results for Z-spectra acquired from the 
prostate cancer patient images with a saturation amplitude of 1.6 µT is plotted in Figure 3.9, with 
deviations from the data indicated with arrows. As with Z-spectra from phantom images, those 
acquired with low saturation amplitudes were more sharply peaked and experienced significant 
oscillation near the edge of the fitting interval. The low order combination models did not 
perform well when the Z-spectra were sharply peaked, and all of the models experienced at least 
some deviations. 
 A representative sample of the curve fitting results for a Z-spectrum acquired from the 
prostate cancer patient images with the saturation amplitude of 4.0 µT is plotted in Figure 3.10. 
The increased saturation amplitude increased the width of the DWS contribution. The 3
rd
 order 
combination model appeared to have inadequacies at this saturation amplitude, indicated by the  
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arrow in Figure 3.10a, while the higher order combination models, shown in Figure 3.10b, 
performed well visually. Oscillations near the edge of the interval were greatly reduced for the 
12
th
 order polynomial model, shown in Figure 3.10c. The 20
th
 order polynomial, shown in Figure 
3.10d, exhibited oscillations near the edge of the interval for this saturation amplitude.  
 
Figure 3.9: The Z-spectrum of the central gland region of the prostate from an image set acquired 
with a saturation amplitude of 1.6 µT. The Z-spectrum was fit with (a) the 3
rd
  order combination 
model, (b) the 6
th
  order combination model, (c) the 12
th
  order polynomial model, and (d) the 
20
th
  order polynomial model. 
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Figure 3.10: The Z-spectrum of the central gland region of the prostate from an image set 
acquired with a saturation amplitude of 4.0 µT. The Z-spectrum was fit with (a) the 3
rd
 order 
combination model, (b) the 6
th
 order combination model, (c) the 12
th
 order polynomial model, 
and (d) the 20
th
 order polynomial model. 
 
3.2.2 PATIENT MODEL SELECTION 
 The distributions of AICc values for the Z-spectra with a saturation amplitude of 1.6 µT 
are displayed as boxplots in Figure 3.11. The average AICc for each model is listed in Table 3.8, 
ordered by increasing average AICc. The combination models outperformed the high order 
polynomial models using the AICc as a metric due to the polynomials’ high ratio of fitting 
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parameters to the number of data points, though this is not visually apparent in Figure 3.9. The 
5
th
 and 6
th
 order combination models outperformed the 3
rd
 and 4
th
 order combination models due 
to their smaller residual sums of squares. The 6
th
 order combination was the preferred model for 
the 1.6 µT saturation amplitude because it had the most negative average AICc. 
 
Figure 3.11: The distributions of AICc values for all regions of the prostate with a saturation 
amplitude of 1.6 µT. The averages indicated on the boxplots are median values.* indicates the 
preferred model. 
 
Table 3.8: AICc results of the models for the saturation amplitude of 1.6 µT for the prostate 
cancer patient images.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 6
th
 order -200.9 23.2 -243.3 -141.8 
2* Combination, 5
th
 order -189.6 20.4 -227.6 -138.2 
3** Combination, 4
th
 order -177.3 20.5 -228.0 -123.1 
4** Combination, 3
rd
 order -176.5 21.8 -224.2 -124.2 
5** Polynomial, 12
th
 order -151.7 17.7 -193.1 -113.2 
6** Polynomial, 20
th
 order -120.7 30.9 -165.2 -42.2 
* indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
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 The distributions of AICc values for the Z-spectra with a saturation amplitude of 2.4 µT 
are displayed as boxplots in Figure 3.12. The average AICc for each model is listed in Table 3.9, 
ordered by increasing average AICc. The combination models outperformed the 20
th
 order 
polynomial model, though the 12
th
 order polynomial model outperformed both the 3
rd
 and 4
th
 
order combination models. The 5
th
 order combination was the preferred model for a 2.4 µT 
saturation amplitude because it had the smallest maximum AICc of the subset of models with the 
most negative but statistically indistinguishable average AICc. 
 
Figure 3.12: The distributions of AICc values for all regions of the prostate with a saturation 
amplitude of 2.4 µT. The averages indicated on the boxplots are median values. * indicates the 
preferred model. 
 
The distributions of AICc values for the Z-spectra with a saturation amplitude of 3.2 µT 
are displayed as boxplots in Figure 3.13. The average AICc values for the saturation amplitude 
of 3.2 µT are listed in Table 3.10, ordered by increasing average AICc. As saturation amplitude 
increased, the Z-spectra broadened, and the performances of the low order polynomials within 
the combination models improved, as seen in Figure 3.10. The visual performance improvement 
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at higher saturation amplitudes seen for the 12
th
 order polynomial model was reflected in the 
AICc values. The 4
th
 order combination was identified as the preferred model because it had the 
most negative maximum AICc value of the subset of models with the most negative but 
statistically indistinguishable average AICc. 
Table 3.9: AICc results of the models for the saturation amplitude of 2.4 µT for the prostate 
cancer patient images.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 5
th
 order -202.6 20.5 -240.3 -158.6 
2 Combination, 6
th
 order -200.3 19.6 -237.9 -154.7 
3 Polynomial, 12
th
 order -195.1 24.7 -243.7 -143.4 
4* Combination, 4
th
 order -193.6 19.4 -236.9 -153.0 
5** Combination, 3
rd
 order -177.2 15.4 -212.5 -141.3 
6** Polynomial, 20
th
 order -122.7 27.5 -183.2 -58.7 
* indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
 
 
Figure 3.13: The distributions of AICc values for all regions of the prostate with a saturation 
amplitude of 3.2 µT. The averages indicated on the boxplots are median values. * indicates the 
preferred model. 
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Table 3.10: AICc results of the models for the saturation amplitude of 3.2 µT for the prostate 
cancer patient images.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 4
th
 order -204.9 24.1 -251.6 -149.1 
2 Combination, 5
th
 order -203.8 23.7 -250.2 -147.2 
3 Combination, 6
th
 order -200.8 23.4 -246.9 -144.5 
4 Polynomial, 12
th
 order -200.7 27.3 -263.4 -133.1 
5** Combination, 3
rd
 order -188.6 18.2 -223.8 -138.3 
6** Polynomial, 20
th
 order -129.5 30.7 -186.9 -54.8 
* indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
 
 The distributions of AICc values for the Z-spectra with a saturation amplitude of 4.0 µT 
are displayed as boxplots in Figure 3.11. The average AICc values are listed in Table 3.12. 
Though there were no statistically significant differences in average AICc value between the 3
rd
, 
4
th
, 5
th
, or 6
th
 combination models or 12
th
 order polynomial model, the 3
rd
 order combination 
model was preferred because it has the most negative maximum AICc.  
 
Figure 3.14: The distributions of AICc values for all regions of the prostate with a saturation 
amplitude of 4.0 µT. The averages indicated on the boxplots are median values. * indicates the 
preferred model. 
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The distributions of AICc values for the Z-spectra at all saturation amplitudes are 
displayed as boxplots in Figure 3.15, and the average AICc values for all saturation amplitudes 
are listed in Table 3.12. There was no significant difference in average AICc values between the 
5
th
 and 6
th
 order combination models. The preferred model considering all saturation amplitudes 
was the 6
th
 order combination model, which had the smallest maximum AICc between the subset 
of models with the most negative but statistically indistinguishable average AICc. 
Table 3.11: AICc results of the models for the saturation amplitude of 4.0 µT for the prostate 
cancer patient images.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 4
th
 order -208.9 23.1 -244.2 -146.9 
2 Combination, 5
th
 order -205.0 23.1 -239.1 -145.4 
3 Combination, 6
th
 order -203.0 22.8 -248.4 -147.3 
4 Combination, 3
rd
 order -201.6 20.6 -233.5 -150.9 
5 Polynomial, 12
th
 order -200.1 27.5 -253.7 -130.3 
6** Polynomial, 20
th
 order -132.1 30.1 -181.7 -71.9 
 * indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
 
 
Figure 3.15: The distributions of AICc values for all regions of the prostate and all saturation 
amplitudes. The averages indicated on the boxplots are median values. * indicates the preferred 
model. 
51 
 
Table 3.12: AICc results of the models for all saturation amplitudes for the prostate cancer 
patient images.  
Rank Model AICcmean σAICc AICcmin AICcmax 
1 Combination, 6
th
 order -201.3 22.2 -248.4 -141.8 
2 Combination, 5
th
 order -200.2 22.7 -250.2 -138.2 
3* Combination, 4
th
 order -196.2 24.9 -251.6 -123.1 
4** Polynomial, 12
th
 order -186.9 31.9 -263.4 -113.2 
5** Combination, 3
rd
  order -186.0 21.6 -233.5 -124.2 
6** Polynomial, 20
th
 order -126.2 30.0 -186.9 -42.2 
* indicates a significant difference (p < 0.05) between the marked model and the model with the 
minimum AICc. ** indicates p < 0.001. 
 
The preferred model selected by the AICc depended on the saturation amplitude. Table 
3.13 lists the preferred fitting model for each of the saturation amplitudes tested. As seen with 
the phantom images, the combination models were preferred to the high order polynomial 
models for all saturation amplitudes tested, and increasing saturation amplitude decreased the 
required order of the polynomial used for the portion of the Z-spectrum upfield from water 
resonance. 
Table 3.13: The preferred fitting models for the prostate cancer patient images as selected by 
AICc for each of the saturation amplitudes tested.  
Saturation Amplitude Preferred Model 
1.6 µT 6
th
 Order Combination 
2.4 µT 5
th
 Order Combination 
3.2 µT 4
th
 Order Combination 
4.0 µT 3
rd
 Order Combination 
All Amplitudes 6
th
 Order Combination 
 
3.3 RESULTS FOR AIM 3: BLADDER CANCER IMAGES 
3.3.1 CURVE FITTING RESULTS 
 The bladder cancer patient images were acquired with a 4.0 µT saturation amplitude. 
Data  points  were  excluded  when  the  signal  intensity  at  a  frequency  offset  fell  below  the 
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threshold of 5% of S0, a procedure consistent with the exclusion procedure for the phantom data 
sets. Because of this, the 4
th
 order combination was selected as the model for fitting the Z-spectra 
rather than the 3
rd
 order combination model preferred for the prostate cancer patient images 
acquired with a 4.0 µT saturation amplitude. 
 A representative example of Z-spectra and the resulting curve fits are plotted for both the 
NBW and tumor regions in Figure 3.16. Generally, the points of the Z-spectra near water 
resonance for tumor regions fell beneath the exclusion threshold. The NBW regions typically had 
higher signal, and few data points were excluded from curve fitting. Seven patients had NBW Z-
spectra that appeared noisy compared to the Z-spectra for other patients. A representative 
example of these Z-spectra and the resulting curve fits are plotted in Figure 3.17. This may be 
due to patient motion during the acquisition. 
 
Figure 3.16: A representative example of Z-spectral curve fits and MTRasym(ω) calculated from 
the interpolated Z-spectra for (a) the NBW region and (b) the tumor region of the bladder cancer 
patient images. 
 
 
53 
 
 
Figure 3.17: An example of (a) a small ROI for the NBW region, and (b) the Z-spectrum in that 
ROI for a patient who may have experienced bladder motion during acquisition. 
 
3.3.2 BLADDER CANCER PATIENT MTR ASYMMETRY RESULTS 
 Using the Shapiro-Wilk test for normality on the distribution of MTRasym(2.0 ppm) and 
MTRasym(3.5 ppm) values in both the NBW and tumor regions, the null hypothesis of normality 
was unable to be rejected, enabling the use of the Student’s t-test. 
 A paired statistically significant difference was found between the MTRasym(3.5 ppm) 
quantities in the NBW and tumor regions (p < 0.001), while no significant difference (p > 0.05) 
was found  between the MTRasym(2.0 ppm) quantities between the NBW and tumor regions. 
 The average MTRasym(3.5 ppm) value in NBW regions was -0.0119 ± 0.0478, while the 
average value in tumor regions was 0.0336 ± 0.0225 (Figure 3.17a). The average MTRasym(2.0 
ppm) value in NBW regions was -0.0020 ± 0.0569, while the average value in tumor regions was 
0.0176 ± 0.0222 (Figure 3.17b).     
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Figure 3.18: Boxplots of the distribution of (a) MTRasym(2.0 ppm) values and (b) MTRasym(3.5 
ppm) values in both the NBW and tumor regions. 
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CHAPTER 4: DISCUSSION AND CONCLUSIONS 
4.1 RESULTS SUMMARY 
 In this work, a Z-spectral curve fitting model was proposed which separated the 
components of the Z-spectrum upfield and downfield from water resonance during the fitting 
process. Reported methods of Z-spectral analysis relied on high order polynomials for 
interpolation, which were not based on the physics of CEST-MRI and were prone to exhibiting 
oscillations near the edge of the fitting interval under some circumstances. The model proposed 
in this work was partially based on the solution to the Bloch equations modified to account for 
the transfer of magnetization between pools of protons either associated with solutes, immobile 
macromolecules, or free water, and relies on lower order polynomials to fit half of the Z-
spectrum. This method of fitting both provided some physically meaningful fitting parameters 
and reduced the magnitude of the oscillations. This method of fitting the upfield and downfield 
sections separately was shown to be preferred based on the AICc model selection criterion. The 
capability of MTRasym calculations made using this model to distinguish tumor from healthy 
tissue was demonstrated for bladder cancer. The motivation for this work was the lack of a 
standard procedure for data processing in CEST-MRI studies, combined with a lack of a standard 
phantom for comparing results across MR systems. 
 It was hypothesized that a model which fit the regions of the Z-spectrum upfield and 
downfield from water separately would result in fits of similar quality as the high order 
polynomial functions reported in the literature while reducing the required number of fitting 
parameters, and thus maintaining the ability to calculate useful MTRasym values. This was tested 
by first applying the models to a comprehensive CEST-MRI phantom and calculating the AICc 
for each to determine a preferred curve fitting model based on the minimum average AICc value. 
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A subset of these models was then applied to a set of prostate cancer patient images and again 
the preferred model was identified as the minimum average AICc. Finally, a model was selected 
from the phantom and prostate cancer results and applied to bladder cancer images; 
MTRasym(2.0 ppm) and MTRasym(3.5 ppm) values were calculated for both NBW and tumor 
regions to determine if these regions could be distinguished by differences in MTR asymmetry 
values. 
For the phantom and prostate cancer patient images acquired at all saturation amplitudes, 
a combination model was preferred using a 5
th
 and 6
th
 order polynomial, respectively, to describe 
the downfield regions of the Z-spectra. A 4
th
 order combination fitting method was applied to 
bladder cancer patient images and the MTRasym(3.5 ppm) calculations were found to be 
significantly different between NBW and tumor regions, demonstrating the ability of 
MTRasym(3.5 ppm) calculations made using this model to distinguish NBW from tumor. 
In addition to incorporating some physical meaning, this model has the potential to be 
extended further to include terms describing Z-spectral contributions from NOE which would 
make it suitable for application to CEST-MRI at ultra-high field strengths (greater than 3 T). 
4.2 LIMITATIONS OF PROPOSED MODEL 
The Lorentzian lineshape describing the effect of DWS in the combination upfield and 
downfield fitting method was based on the solution to modified Bloch equations under the 
assumption of weak saturation (Zhou, Wilson et al. 2004, Zaiß, Schmitt et al. 2011). In many 
experimental conditions, this assumption will not be satisfied as the water signal will be fully 
suppressed at saturation frequency offsets close to water resonance. This could result in large 
variances in MTR asymmetry calculations made in regions where the assumption of weak 
saturation fails. 
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As with all methods for interpolating Z-spectra for MTR asymmetry calculations, 
accurate B0 field inhomogeneity maps are required to ensure accurate calculations. Methods 
which shift the Z-spectrum based on curve fitting results have the advantage of not requiring user 
input when selecting appropriate sequence parameters for acquiring B0 field inhomogeneity 
maps. Figure 3.1 demonstrates variation in B0 field inhomogeneity measurements made using the 
same technique with differences in echo time separation. It has been shown that B0 
inhomogeneities as small as 0.1 ppm can significantly affect the asymmetry calculations (Kim, 
Gillen et al. 2009).  
Separating the curve fitting process into two parts takes additional time to process. While 
not problematic when fitting ROIs, the extra time may become an issue if the technique was 
applied on a per-pixel basis. Processing multiple slices per image data set will add even more 
time. 
The present study only assesses the MTRasym values calculated using a single instance of 
the combination model. This offers no basis for comparing the results of the high order 
polynomial models reported in the literature to the results of the combination model. 
4.3 AIM 1, DISCUSSION 
 Eight fitting models were applied to 84 data sets. Average AICc was calculated for each 
model, with the models then ranked from the most negative average AICc to the largest average 
AICc value. The 20
th
 order polynomial model ranked last in 79 of the 84 data sets tested, and 
ranked next to last for the remaining 5 data sets. Although the 20
th
 order polynomial had the 
lowest residual sum of squares for every data set, it consistently had the largest average AICc 
because of the large ratio of fitting parameters to data points. 
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 At lower saturation amplitudes, the combination model with low order polynomials for 
the downfield region of the Z-spectra generally performed poorly based on the AICc model 
selection criteria, which was the result of the low order polynomial being unable to fit the 
sharper curve in the Z-spectra. This contrasted with the 20
th
 order polynomial which appeared to 
fit the data well but was heavily penalized by the AICc for having many fitting parameters. 
Increasing the saturation amplitude both increased the width of the DWS component of the Z-
spectra and increased the magnitude of the MT component (Zaiß, Schmitt et al. 2011), resulting 
in the shoulders of the Z-spectra being less pronounced; this enabled the lower order polynomials 
to perform better for the combination model. The 20
th
 order polynomial fitting clearly exhibited 
oscillations near the edges of the fitting intervals with the higher saturation amplitudes. 
 Near 0 ppm, where data points were excluded from the fitting process due to falling 
beneath a threshold of signal of 5% of S0, the assumption of weak saturation failed. The 
saturation amplitudes were chosen to reflect values that have been used in past experiments in 
vivo (Jia, Abaza et al. 2011). In the future, imaging with a lower saturation amplitude may be 
preferable to increase the number of data points for which the weak saturation approximation is 
applicable. The performance of the 20
th
 order polynomial model suffered due to this exclusion of 
data points during the curve fitting process, effectively increasing the ratio of the number of 
fitting parameters to the number of data points. 
4.4 AIM 2, DISCUSSION 
Six fitting models were applied to 232 Z-spectral data sets acquired from the prostate 
cancer patient images. Similar to the phantom results, the 20
th
 order polynomial model had the 
greatest average AICc values over all data sets despite having the least residual sum of squares 
values for all data sets. 
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As with the phantom results, the combination models were the preferred curve fitting 
models. The order of the polynomial used to fit the downfield region of the Z-spectra decreased 
with increasing saturation amplitude. This was due to the increase in the MT effect as well as the 
broadening of the DWS component of the Z-spectra, as referenced in the previous section. At 
lower saturation amplitudes, the 3
rd
 and 4
th
 order polynomials used for the combination model 
did not adequately fit the Z-spectra. At higher saturation amplitudes, the combination models 
using 3
rd
 and 4
th
 order polynomials were preferred based on having smaller average AICc values. 
For the Z-spectral data from prostate cancer patient images, data points near the center of 
the Z-spectra were not excluded because of previous experience with these data sets indicating 
that this would not be necessary to achieve good fitting (Schurr, Elias et al. 2014). This previous 
study applied Equation 2.1 to the full set of Z-spectral data. Although regions in the center of the 
Z-spectrum were close to the exclusion threshold applied to the phantom Z-spectra, the quality of 
the fitting was still good based on the average AICc values used for the preferred model 
selection. 
4.5 AIM 3, DISCUSSION 
The 4
th
 order combination model was applied to the bladder cancer patients because this 
had the most negative average AICc values for the phantom at a saturation amplitude of 4.0 µT, 
which was the saturation amplitude used during the acquisition of the bladder cancer patient 
images. The curve fitting procedure in the bladder followed the same exclusion process as in the 
phantom. For this reason, the preferred 4
th
 order combination model from the phantom study was 
selected over the preferred 3
rd
 order combination model from the prostate cancer patient study. 
The MTRasym(3.5 ppm) values were statistically significantly greater in the tumor regions 
than the NBW regions, which showed that this quantity has the potential to distinguish these 
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regions. The MTRasym(2.0 ppm) values were not statistically significantly different between the 
two regions, but this potentially was due to the large saturation amplitude used in the experiment. 
The signal intensity at a frequency offset of ±2.0 ppm was very close to the exclusion threshold 
for many of the Z-spectra. Repeating the experiment with a reduced saturation amplitude may 
yield different results. 
 The Z-spectra collected in the NBW regions for some patients did not have the smooth Z-
spectral shape as shown for the phantom or prostate cancer patient images. This was likely due to 
bladder motion during the imaging procedure. For frequency offsets far from water resonance, 
the ROI can be adjusted to account for motion; however, at frequency offsets close to water 
resonance there is low signal and it is not always possible to account for motion. The ROIs for 
the NBW regions were very small, and the boundaries of the bladder wall were not always clear 
in the CEST-MR images. Though to date there have been no studies on CEST-MRI of bladder 
cancer published and indexed in the PubMed database, the quantity MTRasym(3.5 ppm) has been 
shown in studies of other sites to have the ability to distinguish disease from healthy tissue (Jia, 
Abaza et al. 2011). 
4.6 DIRECTION OF FUTURE WORK 
Future work on this fitting model may need to constrain the slopes of the fits in the 
upfield and downfield regions to match at the origin to prevent artifacts in MTR asymmetry 
calculations at saturation frequency offsets close to water resonance. This will become more 
important at lower saturation amplitudes, or for imaging solutes which exhibit a CEST effect 
near water resonance such as glycogen. Eventually, the combination model for curve fitting 
could be written into a standalone image processing software and made available for use by the 
community. 
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Establishing MTRasym calculations as a clinically relevant quantitative imaging biomarker 
will require additional work to establish the scan-rescan and cross-system reproducibility. A 
standard CEST-MRI phantom will be useful for this process, and the phantom used in this study 
could be modified for this role. The size of the phantom should be reduced to enable it to fit in 
smaller detector coils. Changing the temperature or pH of the phantoms may be useful as well. 
If new terms were added to the fitting model to account for NOE, the model could be 
applied to CEST-MRI at ultra-high field strengths. Many CEST-MRI studies are performed at 
field strengths greater than 3 T, and adapting the model to apply to these conditions would 
increase the number of studies for which the model would be relevant. 
The bladder cancer study could be extended to include patient images from follow-up 
MR scans. For patients undergoing chemotherapy for instance, one could assess changes in 
MTRasym in response to therapy. Another venue is to assess whether MTRasym can predict a 
patient’s response to chemotherapy. 
In conclusion, the Z-spectral analysis method proposed in this study of fitting the upfield 
and downfield regions of the Z-spectrum separately provided a better model than some higher 
order polynomial models reported in the literature, according to the AICc model selection 
criteria. This was demonstrated in both phantom and patient images using multiple amplitudes 
for the saturation pre-pulse. Additionally, the model provided a model based in part on the 
physics of MT-MRI and CEST-MRI. The application of the model to bladder cancer patients 
demonstrated that the MTRasym(3.5 ppm) calculations performed using the combination can 
provide quantitative methods of distinguishing NBW from bladder cancer, a site which has not 
been previously studied by with CEST-MRI.   
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